Phone: (310) 794-7700
Join the conversation on Twitter at @UCLAHealth with hashtag #UCLAMDChat Tweets about "#UCLAMDChat"
UCLA oncologist Sandy Liu, MD, talked about UCLA’s multi-disciplinary treatment approach to target advanced kidney cancer. The team approaches each case individually with the hope of eradicating all disease with aggressive systemic therapy and, when feasible, adding multi-modal therapy to consolidate residual disease.
View Webinar >
UCLA urologist Robert Reiter, MD, presented a live-streaming webinar to discuss Ga-PSMA PET CT, a new method for detection and visualization of metastatic prostate cancer not previously visible with conventional and molecular imaging techniques. Ga-PSMA PET CT is now offered at UCLA and aims to improve management of recurrent and high-risk cancers.
View Webinar >
Note: Investigational agent. Currently not approved by FDA for imaging prostate cancer.
UCLA urologist Leonard Marks, MD, presented a live-streaming webinar to discuss HIFU (high intensity focused ultrasound).
View Webinar >
UCLA Urologist Mark Litwin, MD, presented a live-streaming webinar to discuss the basics of testicular cancer diagnosis and treatment. He presented a path to cure for almost all men.
View Webinar >
On Wednesday, April 6, 2016, 11:30 am PST, UCLA urologist Leonard Marks, MD, presented a live-streaming webinar to discuss the benefits of combining the sensitivity of MRI with the convenience of ultrasound to greatly increase accuracy of prostate biopsy. MRI fusion with ultrasound provides the ability to map and target biopsies.
View Webinar >
On April 22, 2015, UCLA urologist, Dr. Mark S. Litwin, presented a live-streaming webinar to discuss common misconceptions about testicular cancer. He also presented an insider’s view of what to do if you have a lump in the testicle or have been told you have testicular cancer.
View Webinar >
On Wed, Mar 11, 2015 at 11:30 AM PDT, Allan J. Pantuck, MD, MS, FACS, professor in the UCLA Department of Urology presented a live-streaming webinar to discuss the use of Provenge in the treatment of prostate cancer. Dr. Pantuck discussed the background and rationale for the use of immune-based therapies in the treatment of cancer and the indications, benefits and side effects of Provenge, an FDA-approved treatment for advanced prostate cancer that utilizes the patient’s genetically engineered immune cells. What is Provenge? Provenge Vaccine for Prostate Cancer at UCLA >
View Webinar >
UCLA urologist Robert Reiter, MD - Surgeons increasingly are using robotic surgery to operate on patients, resulting in less blood loss, less pain and faster recovery. Since 2003, UCLA urologic surgeons have performed more than 3,000 procedures robotically to treat prostate, bladder and kidney cancer.
View Video >
